Original Research
Published on 12 Feb 2024
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study
in Genitourinary Oncology
- 1,933 views
- 1 citation